E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/25/2006 in the Prospect News Biotech Daily.

Gene Logic extends agreement with Affymetrix

By Lisa Kerner

Erie, Pa., Jan. 25 - Gene Logic Inc. said it entered into a service provider agreement with Affymetrix, Inc. to buy microarrays, instrumentation, reagents and services from Affymetrix.

This new one-year agreement succeeds the companies' amended and restated agreement that expired on Dec. 31.

Under the latest agreement, Gene Logic agreed to spend a minimum of $7,625,000 on products and services in 2006. Gene Logic is not required to pay annual license fees or, unless Gene Logic defaults on its purchase obligation, royalties on database licenses and sales accruing after Dec. 31.

The agreement sets prices for the Affymetrix products purchased during the one-year term.

Gene Logic, based in Gaithersburg, Md., provides drug discovery and development solutions.

Affymetrix provides microarray technology used in molecular biology research. The company is based in Santa Clara, Calif.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.